SMA Newborn Screening Kits
- NHS Greater Glasgow and Clyde
Procurement identifier (OCID): ocds-h6vhtk-066e98
Description
The Scottish Newborn Screening Laboratory has been commissioned to participate in the in-service evaluation for Spinal Muscular Atrophy (SMA) organised by the National Screening Committee. NHSGG&C require newborn screening kits that measure both SMN1 and SMN2 genes simultaneously. The SMN2 copy number must be screened for at the same time as the SMN1 deletion in keeping with the Scottish screening protocol. The requirement is to screen dried blood spot samples from newborn babies for Spinal Muscular Atrophy (SMA).
Notices
F03: Contract award notice
- Notice identifier
- 2026/S 000-031045
- Published
- 2 April 2026, 3:29pm
F15: Voluntary ex ante transparency notice
- Notice identifier
- 2026/S 000-025039
- Published
- 19 March 2026, 10:53am